Literature DB >> 31431305

Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study.

Yasuharu Tabara1, Katsuhiko Kohara2, Yoko Okada3, Yasumasa Ohyagi3, Michiya Igase4.   

Abstract

BACKGROUND: Sarcopenia increases mortality risk in older adults. Loss of skeletal muscle mass is a cardinal feature of sarcopenia. The creatinine-to-cystatin C ratio (CCR) has been suggested as a marker of muscle mass. The present study investigated the usefulness of CCR in discriminating the risk of low muscle mass and weak muscle strength in an elderly population.
METHODS: The present cross-sectional study included 1,329 apparently healthy community residents aged 60 years or older. The cross-sectional area (CSA) of muscle in the mid-thigh was measured using computed tomography. Clinical data recorded at routine medical check-ups were obtained from each participant's medical record.
RESULTS: Mean muscle CSA was 109 ± 24 cm2. CCR by quartiles according to sex was strongly associated with muscle CSA (Q1: 104 ± 22, Q2: 108 ± 24, Q3: 110 ± 23, and Q4: 114 ± 25 cm2, F = 10.38, P < 0.001). This association was independent of major covariates (Q1: reference, Q2: β = 0.06, P < 0.001, Q3: β = 0.10, P < 0.001, and Q4: β = 0.17, P < 0.001) even in a sex-separated analysis. Although creatinine alone was independently associated with muscle CSA (F = 5.81, P < 0.001), the association was weaker than that of CCR, particularly in the individuals with renal functional decline. Also, CCR was associated with grip strength independently of muscle CSA.
CONCLUSION: CCR was a simple marker of low muscle mass and weak muscle strength in older community-dwelling adults.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Creatinine; Cystatin C; General population; Sarcopenia; Skeletal muscle

Year:  2019        PMID: 31431305     DOI: 10.1016/j.clnu.2019.07.027

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  11 in total

1.  Risk Factors for the Incident Decline of Physical Performance in Older Men: The Prospective Strambo Study.

Authors:  Philippe Paul Wagner; Dominique Foesser; Roland Chapurlat; Pawel Szulc
Journal:  Calcif Tissue Int       Date:  2021-10-30       Impact factor: 4.333

2.  Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project.

Authors:  Kenichiro Mikami; Tetsu Endo; Naoya Sawada; Go Igarashi; Masayo Kimura; Takuma Hasegawa; Chikara Iino; Kaori Sawada; Masataka Ando; Yoshikuni Sugimura; Tatsuya Mikami; Shigeyuki Nakaji; Masashi Matsuzaka; Hirotake Sakuraba; Shinsaku Fukuda
Journal:  J Clin Biochem Nutr       Date:  2021-11-26       Impact factor: 3.179

3.  Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study.

Authors:  Shanhu Qiu; Xue Cai; Bo Xie; Yang Yuan; Zilin Sun; Tongzhi Wu
Journal:  Diabetes Metab J       Date:  2022-03-07       Impact factor: 5.893

4.  Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list.

Authors:  Ezequiel Mauro; Juan Manuel Diaz; Lucrecia Garcia-Olveira; Juan Carlos Spina; Lorena Savluk; Fernanda Zalazar; Julia Saidman; Martin De Santibañes; Juan Pekolj; Eduardo De Santibañes; Gonzalo Crespo; Juan G Abraldes; Adrían Gadano
Journal:  Hepatol Commun       Date:  2022-03-03

5.  Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults.

Authors:  Lingling Tan; Ruicen Li; Xiaoyi Hu; Yuan Zhu; Ting Bao; Yun Zuo; Ming Yang
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

6.  Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease.

Authors:  Shaobo Li; Jing Lu; Geng Gu; Wenkun Bai; Yafen Ye; Yuqian Bao; Haoyong Yu; Junfeng Han
Journal:  Front Physiol       Date:  2021-04-07       Impact factor: 4.566

7.  Nutritional and Non-Nutritional Predictors of Low Spot Urinary Creatinine Concentration in Patients with Heart Failure.

Authors:  Jolanta Malinowska-Borowska; Aleksandra Kulik; Marta Buczkowska; Weronika Ostręga; Apolonia Stefaniak; Małgorzata Piecuch; Jagoda Garbicz; Jolanta Urszula Nowak; Mateusz Tajstra; Ewa Anita Jankowska; Mariusz Gąsior; Piotr Rozentryt
Journal:  Nutrients       Date:  2021-11-09       Impact factor: 5.717

8.  Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Yoshitaka Hashimoto; Fuyuko Takahashi; Takuro Okamura; Takafumi Osaka; Hiroshi Okada; Takafumi Senmaru; Saori Majima; Emi Ushigome; Naoko Nakanishi; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  BMJ Open Diabetes Res Care       Date:  2022-06

9.  Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease.

Authors:  Young Youl Hyun; Kyu-Beck Lee; Hyoungnae Kim; Yaeni Kim; Wookyung Chung; Hayne Cho Park; Seung Hyeok Han; Yun Kyu Oh; Sue Kyung Park; Kook-Hwan Oh
Journal:  Front Nutr       Date:  2022-09-26

10.  [Quantitative analysis of tryptophan and its metabolites in urine by ultra performance liquid chromatography-tandem mass spectrometry].

Authors:  Hui Li; Lanchong Cui; Guolei Zhang; Mengmeng Zhang; Lili Jiao; Wei Wu
Journal:  Se Pu       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.